Get started
Author

Juliette Verhille

Observed names: J. Verhille, Juliette VERHILLE
OpenAlex ID: A5073764982
The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study
2024 · Pierre-Régis Burgel, Isabelle Sermet-Gaudelus, et al. · The Lancet Respiratory Medicine · 63
Sweat chloride and lung function responses to elexacaftor–tezacaftor–ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studies
2025 · Pierre-Régis Burgel, Jennifer Da Silva, et al. · The Lancet Respiratory Medicine · 18
Evolution and factors associated with presenteeism in severe asthma after treatment with biologics
2025 · Justine Subocz, Thomas Stoup, et al. · Respiratory Medicine · 1
PDF
Improvement of exertional dyspneoa in patients with chronic obstructive pulmonary disease and severe allergic asthma responding to omalizumab
2023 · Sophie Pereira, Juliette Verhille, et al. · Clinical & Experimental Allergy · 1
PDF
Pathogenic respiratory microbiota in cystic fibrosis: impact of 2 years of triple CFTR modulator therapy
2026 · Caroline Demeule, Lucie Amoureux, et al. · Clinical Microbiology and Infection
Evolution and factors associated with presenteeism in severe asthma after treatment with biologics
2025 · Justine Subocz, Thomas Stoup, et al. · European Respiratory Journal
Evolution and Factors Associated With Presenteeism in Severe Asthma After Treatment With Biologics
2025 · J. Subocz, T. Stoup, et al. · American Journal of Respiratory and Critical Care Medicine
Role of CXCL12/CXCR4 pathway and miRNA expression profiles on polymorphonuclear mobilization in COVID-19 patients
2025 · Matthieu Daniel, Faustine Bernardin, et al. · Research Square
PDF
Improvement of exertional dyspnea in patients with COPD and severe allergic asthma responding to omalizumab
2024 · Sophie Pereira, Juliette Verhille, et al. · Biological Psychology
Omalizumab in severe allergic asthma associated with COPD: a multicentric cohort study
2021 · Sophie Pereira, Nathalie Bautin, et al. · European Respiratory Journal
Omalizumab chez les patients ayant un asthme sévère allergique associé à une bronchopneumopathie chronique obstructive : une étude de cohorte monocentrique
2018 · J. Verhille, J. Giovannelli, et al. · Revue des Maladies Respiratoires
Works count: 11
Citation count: 83
H-index: 2
I10-index: 2
Year
Topic
Type